https://www.globenewswire.com/news-release/2019/09/25/1920526/0/en/AzurRx-BioPharma-Announces-Positive-Results-from-Phase-2-Trial-with-MS1819-in-Cystic-Fibrosis-Patients.html AzurRx BioPharma Announces Positive Results from Phase 2 Trial with MS1819 in Cystic Fibrosis Patients
